News for AxoGen, Inc. (AXGN)

On May 19, 2025, Joseph Tyndall, a Director at Axogen Inc (AXGN), sold 2,525 shares of the company, according to a SEC Filing. Following this transaction, the i

In recent analyst activity, Axogen (AXGN) has been the subject of a price target adjustment by Canaccord Genuity. Analyst Caitlin Cronin from Canaccord Genuity

Axogen, Inc. (NASDAQ:AXGN) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsMichael Dale - Chairman & Chief Executive...

Release Date: May 08, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Axogen Inc (AXGN)

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NAXGN.OQ - AxoGen IncQ1 2025 AxoGen Inc Earnings CallMay 08, 2025 / 12:00PM GMT ===============

Raymond James analyst Jayson Bedford has revised the price target for AxoGen (AXGN), decreasing it from $25 to $21, although he maintains an Outperform rating f

**media[618815]**

ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative ...

Axogen and ADMA Biologics foresee minimal impact from President Trump's tariffs, highlighting strong domestic operations and resilient supply chains. Read more here.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Full Year 2024 Revenue: USD 187.3 million, a 17.8% increase compared to 2023.Fourth Quarter 2024 Revenue: USD 49.4 million, up 15.1% compared to the prior year

Feb 25, 2025 / 01:00PM GMTOperator Good morning everyone. Joining me on today's call is Michael Dale, AxoGen's Chief Executive Officer and director, and Nir Nao

Axogen, Inc. (NASDAQ:AXGN) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ETCompany ParticipantsMichael Dale - Chairman and Chief Executive...

Quarterly Revenue: $49.4 million, surpassing the estimated $48.57 million and marking a 15.1% increase from the same quarter last year.Quarterly EPS: $0.01, ex

ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. ( AXGN), a global leader in developing and marketing innovative surgical solutio

Transaction Overview On December 31, 2024, First Light Asset Management, LLC (Trades, Portfolio) executed a significant reduction in its holdings of KORU Medica

**media[538156]**

On December 31, 2024, First Light Asset Management, LLC (Trades, Portfolio) made a significant move by acquiring an additional 2,851,982 shares of Health Cataly

ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. ( AXGN), a global leader in developing and marketing innovative surgical solutio